Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001963036 | SCV002243484 | pathogenic | Tuberous sclerosis 2 | 2023-10-13 | criteria provided, single submitter | clinical testing | This sequence change is a complex rearrangement involving exons 1-35 of the TSC2 gene, including a copy number gain of exons 22-35. Although the exact nature of the event is unknown, it is likely that this is a large inversion event, that would either disrupt the transcription or result in a truncated protein product. This variant has not been reported in the literature in individuals affected with TSC2-related conditions. For these reasons, this variant has been classified as Pathogenic. |